{"id":"W4392882147","doi":"10.1016/j.ijpharm.2024.124009","title":"Nasal delivery of encapsulated recombinant ACE2 as a prophylactic drug for SARS-CoV-2","year":2024,"lang":"en","type":"article","venue":"International Journal of Pharmaceutics","topic":"Inhalation and Respiratory Drug Delivery","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"British Columbia Institute of Technology; University of British Columbia","funders":"National Health and Medical Research Council; Natural Sciences and Engineering Research Council of Canada","keywords":"Recombinant DNA; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Nasal cavity; Nasal administration; Coronavirus disease 2019 (COVID-19); Chemistry; Virus; Virology; Pharmacology; Nose; Enzyme; Drug delivery; Medicine; Biochemistry; Pathology; Surgery; Infectious disease (medical specialty); Gene","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001723956,0.0002883649,0.0003503993,0.0001097448,0.00009200406,0.0002570175,0.0002026282,0.0003339114,0.0005172385],"category_scores_gemma":[0.000126837,0.0001128573,0.0003346759,0.00007937317,0.0001539586,0.0002282946,0.0001826813,0.0004070748,0.0001557588],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001935181,"about_ca_system_score_gemma":0.0001611464,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004642294,"about_ca_topic_score_gemma":0.0006374621,"domain_scores_codex":[0.9998806,0.0000198975,0.000008383168,0.00002625674,0.0000417246,0.00002323345],"domain_scores_gemma":[0.9999537,0.000009575282,0.00001271514,0.000005530065,0.000009192901,0.000009201199],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00009291527,0.00004682185,0.00004807338,0.00006954042,0.000006966505,0.00005227386,0.000009139508,0.00008352392,0.9977618,0.00003666687,0.00004426114,0.001747924],"study_design_scores_gemma":[0.00002920222,0.0007539519,0.0006667497,0.000007168669,0.00002074709,0.0001496601,0.00001232844,0.001152948,0.9953335,0.00001180449,0.001856772,0.000005114112],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.987413,0.003696895,0.006891452,0.0001363069,0.0001107256,0.0001075915,0.0002061632,0.00008886338,0.00134898],"genre_scores_gemma":[0.9869518,0.001814736,0.008459749,0.0001054147,0.00002472106,0.00005830544,0.0002440885,0.00002230878,0.00231886],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0005172385,"threshold_uncertainty_score":0.001730382,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05413853659704235,"score_gpt":0.4099872590432733,"score_spread":0.3558487224462309,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}